The new business model, particularly AI to drive the efficiency of BMRI screening enables an 80% reduction in the cost of Aurora’s BMRI as a population screening and diagnostic system.  The suite of Aurora’s system of hardware, software and service makes BMRI primary screening and secondary diagnostics accessible and affordable to literally hundreds of millions of women in middle-income countries who now have little to no access to breast cancer screening and early diagnosis.